サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は小細胞肺がんの治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは小細胞肺がんの治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の小細胞肺がんの治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは小細胞肺がんの治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に小細胞肺がんの治療市場を分類しています。本研究に含まれる主な企業は：Sanofi、Bristol-Myers Squibb、GlaxoSmithKline、Menarini、Ziopharm Oncology、Merck、Novartis、AstraZeneca、Takeda Pharmaceutical、Teva Pharmaceutical、Eli Lilly、Mylan、Sun Pharmaceuticals Industries、Amgen、Ono Pharmaceutical、Shanghai Jinhe Bio-Technology

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Biologics
    Small Molecules

用途別の市場セグメント：
    Hospitals
    Clinics
    Other

本レポートの詳細内容
世界の小細胞肺がんの治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、小細胞肺がんの治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の小細胞肺がんの治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の小細胞肺がんの治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、小細胞肺がんの治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

小細胞肺がんの治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：小細胞肺がんの治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：小細胞肺がんの治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章小細胞肺がんの治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：小細胞肺がんの治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：小細胞肺がんの治療の主要企業の概要を提供し、製品の説明と仕様、小細胞肺がんの治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell carcinoma. It can be further classified into two stages: limited-stage small cell lung cancer and extensive-stage small cell lung cancer. Small cell lung cancer is caused by smoking tobacco, or second hand smoking, or on exposure to asbestos, chromium, arsenic, nickel, soot, or radon. The common symptoms associated with lung cancer are chest pain, incurable cough, blood in sputum, fatigue, loss of appetite, unintentional weight loss, shortness of breath, and wheezing. Small cell lung cancer has a poor prognosis and gets diagnosed only at the late stage of disease progression, and hence, has a high mortality rate. There are no therapies available to cure small cell lung cancer in the market.
Market Analysis and Insights: Global Small Cell Lung Cancer Therapeutics Market
The global Small Cell Lung Cancer Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Small Cell Lung Cancer Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Small Cell Lung Cancer Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Small Cell Lung Cancer Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Small Cell Lung Cancer Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Small Cell Lung Cancer Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Small Cell Lung Cancer Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, Bristol-Myers Squibb, GlaxoSmithKline, Menarini, Ziopharm Oncology, Merck, Novartis, AstraZeneca and Takeda Pharmaceutical, etc.

Market Segmentation
By Company
    Sanofi
    Bristol-Myers Squibb
    GlaxoSmithKline
    Menarini
    Ziopharm Oncology
    Merck
    Novartis
    AstraZeneca
    Takeda Pharmaceutical
    Teva Pharmaceutical
    Eli Lilly
    Mylan
    Sun Pharmaceuticals Industries
    Amgen
    Ono Pharmaceutical
    Shanghai Jinhe Bio-Technology

Segment by Type
    Biologics
    Small Molecules

Segment by Application
    Hospitals
    Clinics
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Small Cell Lung Cancer Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Cell Lung Cancer Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Small Cell Lung Cancer Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Biologics
    Table 3. Key Players of Small Molecules
    Table 4. Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Small Cell Lung Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Small Cell Lung Cancer Therapeutics Market Share by Region (2019-2024)
    Table 8. Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Small Cell Lung Cancer Therapeutics Market Share by Region (2025-2030)
    Table 10. Small Cell Lung Cancer Therapeutics Market Trends
    Table 11. Small Cell Lung Cancer Therapeutics Market Drivers
    Table 12. Small Cell Lung Cancer Therapeutics Market Challenges
    Table 13. Small Cell Lung Cancer Therapeutics Market Restraints
    Table 14. Global Small Cell Lung Cancer Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Small Cell Lung Cancer Therapeutics Revenue Share by Players (2019-2024)
    Table 16. Global Top Small Cell Lung Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Cell Lung Cancer Therapeutics as of 2023)
    Table 17. Global Small Cell Lung Cancer Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Small Cell Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Small Cell Lung Cancer Therapeutics, Headquarters and Area Served
    Table 20. Global Key Players of Small Cell Lung Cancer Therapeutics, Product and Application
    Table 21. Global Key Players of Small Cell Lung Cancer Therapeutics, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Small Cell Lung Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2019-2024)
    Table 25. Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2025-2030)
    Table 27. Global Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Small Cell Lung Cancer Therapeutics Revenue Share by Application (2019-2024)
    Table 29. Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Small Cell Lung Cancer Therapeutics Revenue Share by Application (2025-2030)
    Table 31. North America Small Cell Lung Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Small Cell Lung Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Small Cell Lung Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Small Cell Lung Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Small Cell Lung Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Small Cell Lung Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Small Cell Lung Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Small Cell Lung Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Small Cell Lung Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Small Cell Lung Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Small Cell Lung Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Small Cell Lung Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Small Cell Lung Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Small Cell Lung Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Small Cell Lung Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Small Cell Lung Cancer Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Small Cell Lung Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Small Cell Lung Cancer Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Sanofi Company Details
    Table 64. Sanofi Business Overview
    Table 65. Sanofi Small Cell Lung Cancer Therapeutics Product
    Table 66. Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 67. Sanofi Recent Developments
    Table 68. Bristol-Myers Squibb Company Details
    Table 69. Bristol-Myers Squibb Business Overview
    Table 70. Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Product
    Table 71. Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 72. Bristol-Myers Squibb Recent Developments
    Table 73. GlaxoSmithKline Company Details
    Table 74. GlaxoSmithKline Business Overview
    Table 75. GlaxoSmithKline Small Cell Lung Cancer Therapeutics Product
    Table 76. GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 77. GlaxoSmithKline Recent Developments
    Table 78. Menarini Company Details
    Table 79. Menarini Business Overview
    Table 80. Menarini Small Cell Lung Cancer Therapeutics Product
    Table 81. Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 82. Menarini Recent Developments
    Table 83. Ziopharm Oncology Company Details
    Table 84. Ziopharm Oncology Business Overview
    Table 85. Ziopharm Oncology Small Cell Lung Cancer Therapeutics Product
    Table 86. Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 87. Ziopharm Oncology Recent Developments
    Table 88. Merck Company Details
    Table 89. Merck Business Overview
    Table 90. Merck Small Cell Lung Cancer Therapeutics Product
    Table 91. Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 92. Merck Recent Developments
    Table 93. Novartis Company Details
    Table 94. Novartis Business Overview
    Table 95. Novartis Small Cell Lung Cancer Therapeutics Product
    Table 96. Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 97. Novartis Recent Developments
    Table 98. AstraZeneca Company Details
    Table 99. AstraZeneca Business Overview
    Table 100. AstraZeneca Small Cell Lung Cancer Therapeutics Product
    Table 101. AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 102. AstraZeneca Recent Developments
    Table 103. Takeda Pharmaceutical Company Details
    Table 104. Takeda Pharmaceutical Business Overview
    Table 105. Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Product
    Table 106. Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 107. Takeda Pharmaceutical Recent Developments
    Table 108. Teva Pharmaceutical Company Details
    Table 109. Teva Pharmaceutical Business Overview
    Table 110. Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Product
    Table 111. Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 112. Teva Pharmaceutical Recent Developments
    Table 113. Eli Lilly Company Details
    Table 114. Eli Lilly Business Overview
    Table 115. Eli Lilly Small Cell Lung Cancer Therapeutics Product
    Table 116. Eli Lilly Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 117. Eli Lilly Recent Developments
    Table 118. Mylan Company Details
    Table 119. Mylan Business Overview
    Table 120. Mylan Small Cell Lung Cancer Therapeutics Product
    Table 121. Mylan Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 122. Mylan Recent Developments
    Table 123. Sun Pharmaceuticals Industries Company Details
    Table 124. Sun Pharmaceuticals Industries Business Overview
    Table 125. Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Product
    Table 126. Sun Pharmaceuticals Industries Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 127. Sun Pharmaceuticals Industries Recent Developments
    Table 128. Amgen Company Details
    Table 129. Amgen Business Overview
    Table 130. Amgen Small Cell Lung Cancer Therapeutics Product
    Table 131. Amgen Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 132. Amgen Recent Developments
    Table 133. Ono Pharmaceutical Company Details
    Table 134. Ono Pharmaceutical Business Overview
    Table 135. Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Product
    Table 136. Ono Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 137. Ono Pharmaceutical Recent Developments
    Table 138. Shanghai Jinhe Bio-Technology Company Details
    Table 139. Shanghai Jinhe Bio-Technology Business Overview
    Table 140. Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Product
    Table 141. Shanghai Jinhe Bio-Technology Revenue in Small Cell Lung Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 142. Shanghai Jinhe Bio-Technology Recent Developments
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Small Cell Lung Cancer Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Biologics Features
    Figure 4. Small Molecules Features
    Figure 5. Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Small Cell Lung Cancer Therapeutics Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Other Case Studies
    Figure 10. Small Cell Lung Cancer Therapeutics Report Years Considered
    Figure 11. Global Small Cell Lung Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Small Cell Lung Cancer Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Small Cell Lung Cancer Therapeutics Market Share by Region: 2023 VS 2030
    Figure 14. Global Small Cell Lung Cancer Therapeutics Market Share by Players in 2023
    Figure 15. Global Top Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Cell Lung Cancer Therapeutics as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Small Cell Lung Cancer Therapeutics Revenue in 2023
    Figure 17. North America Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Small Cell Lung Cancer Therapeutics Market Share by Type (2019-2030)
    Figure 19. North America Small Cell Lung Cancer Therapeutics Market Share by Application (2019-2030)
    Figure 20. North America Small Cell Lung Cancer Therapeutics Market Share by Country (2019-2030)
    Figure 21. United States Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Small Cell Lung Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Small Cell Lung Cancer Therapeutics Market Share by Type (2019-2030)
    Figure 25. Europe Small Cell Lung Cancer Therapeutics Market Share by Application (2019-2030)
    Figure 26. Europe Small Cell Lung Cancer Therapeutics Market Share by Country (2019-2030)
    Figure 27. Germany Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Small Cell Lung Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Small Cell Lung Cancer Therapeutics Market Share by Type (2019-2030)
    Figure 35. China Small Cell Lung Cancer Therapeutics Market Share by Application (2019-2030)
    Figure 36. Asia Small Cell Lung Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Small Cell Lung Cancer Therapeutics Market Share by Type (2019-2030)
    Figure 38. Asia Small Cell Lung Cancer Therapeutics Market Share by Application (2019-2030)
    Figure 39. Asia Small Cell Lung Cancer Therapeutics Market Share by Region (2019-2030)
    Figure 40. Japan Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Small Cell Lung Cancer Therapeutics Market Share by Country (2019-2030)
    Figure 50. Brazil Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Sanofi Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 59. Menarini Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 60. Ziopharm Oncology Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 61. Merck Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 62. Novartis Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 63. AstraZeneca Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 65. Teva Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 66. Eli Lilly Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 67. Mylan Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 68. Sun Pharmaceuticals Industries Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 69. Amgen Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 70. Ono Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 71. Shanghai Jinhe Bio-Technology Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed